Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$147.4K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 6,952 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 18,750 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 27,224 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 14,799 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 82,500 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 21,381 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 8,482 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 4,909 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 36,606 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 18,303 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 18,303 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 36,606 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 36,606 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 19,006 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 19,006 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 41,250 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 41,250 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 114,591 | — | — | -100.0% | Open the original filing on SEC.gov |
| Feb 11 | APLS | Apellis Pharmaceuticals,… | SSELL | 368 | $22.15 | $8.2K | -0.3% | Open the original filing on SEC.gov |
| Jan 28 | APLS | Apellis Pharmaceuticals,… | AGRANT | 36,606 | — | — | +46.7% | Open the original filing on SEC.gov |
| Jan 22 | APLS | Apellis Pharmaceuticals,… | SSELL | 3,371 | $21.77 | $73.4K | -4.1% | Open the original filing on SEC.gov |
| Jan 20 | APLS | Apellis Pharmaceuticals,… | SSELL | 1,334 | $19.79 | $26.4K | -1.6% | Open the original filing on SEC.gov |
| Jan 13 | APLS | Apellis Pharmaceuticals,… | SSELL | 1,780 | $22.19 | $39.5K | -2.1% | Open the original filing on SEC.gov |
| Jun 9, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT◆ | 82,500 | $19.39 | $1.6M | — | Open the original filing on SEC.gov |